Litigation: SEC Charges North Carolina Resident With Insider Trading in Massachusetts-Based Biopharmaceutical Company
October 16, 2024
October 16, 2024
WASHINGTON, Oct. 16 -- The Securities and Exchange Commission issued the following litigation release (No. 1:24-cv-12621; D. Mass. filed Oct. 15, 2024) involving Matthew Groom:
* * *
The Securities and Exchange Commission filed insider trading charges today against North Carolina resident Matthew Groom, who allegedly avoided losses of about $13,000 by trading in advance of the May 3, 2022 announcement by the Cambridge, Massachusetts-based biopharmaceutical company Spero . . .
* * *
The Securities and Exchange Commission filed insider trading charges today against North Carolina resident Matthew Groom, who allegedly avoided losses of about $13,000 by trading in advance of the May 3, 2022 announcement by the Cambridge, Massachusetts-based biopharmaceutical company Spero . . .